Global oncology data Epiphany Partners offers EpiOncology, a global oncology epidemiology platform spanning 42+ countries and 110+ cancer sites, presenting a scalable opportunity to upsell expanded data access and deeper analytics capabilities to pharmaceutical, biotech, HEOR, and market research clients.

Strategic decision support The company focuses on making oncology forecasting and market evaluation more transparent and faster, suggesting sales potential in consulting services, custom analyses, and cross-functional workshops for oncology teams seeking actionable insights.

Small team, niche expertise With a lean team and decades of domain experience, Epiphany Partners can deliver high-value, specialized services quickly, appealing to mid-market clients seeking expert epidemiology data without large enterprise engagements.

Recurring revenue potential Existing platform and data subscriptions across multiple cancer sites imply opportunities for annual or multi-year licensing, renewals, and tiered data access, as well as add-on modules or premium datasets.

Tech-enabled partnerships Their technology stack and cloud-based data platform position Epiphany as a partner for embedded analytics, UI integrations, and co-development of forecasting tools within client ecosystems, expanding cross-sell opportunities to technology-driven buyers.